Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — Cellectis S.A. (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company…
Initiated Phase 1/1b clinical trial of NGM831, an ILT3 antagonist antibody product candidate, as a monotherapy and in combination with…
Montrouge, France, May 5, 2022 DBV Technologies Completes ADSs Sale of an amount of $15.3 million on Nasdaq through its…
Athira Urges Shareholders to Vote “FOR” Athira’s Highly Qualified, Independent Director Nominees – Joseph Edelman, John M. Fluke, Jr. and…
PURCHASE, N.Y., May 04, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Cognition…
ANJESO® Net Product Revenue Up 113% Compared to Same Period in Prior Year; Sixth Consecutive Quarter of Demand Growth First…
SAN CARLOS, Calif., May 04, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on…
MILAN, Italy and NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) — Genenta Science S.p.A. (NASDAQ: GNTA), a clinical-stage biotechnology company…
RESEARCH TRIANGLE PARK, N.C., May 04, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee…
First Quarter Net Revenue of $2.2 Million;Active Customer Sites Climb 17% to New Record SOUTH ORANGE, NJ, May 04, 2022…